HealthCor Partners follows a differentiated, growth-oriented investment strategy that leverages the unique strengths of the HealthCor Group and its reputation as one of the preeminent healthcare and life sciences investment management firms in the United States. The 25+ person HealthCor Group team of investment professionals, of whom are all exclusively focused on the healthcare and life sciences industry, provide HealthCor Partners with significant research and relationships. As a result, HealthCor Partners effectively has far greater resources than the typical $300 million private equity fund.

The key features of HealthCor Partners' investment strategy are as follows:

HealthCor Partners makes equity and equity-related investments between $5 to $25 million in each portfolio company employing a variety of methods, including: (i) making minority and/or control investments in later stage developmental companies that exhibit favorable asymmetrical risk/reward characteristics; (ii) making significant minority and/or control investments in rapidly growing (private or publicly traded) mid-sized healthcare and life sciences companies; (iii) backing experienced management teams in leveraged buyouts and in creating growing companies through a series of acquisitions (referred to as "build-ups"); and selectively (iv) investing in restructurings, recapitalizations and other "special situations" involving more established healthcare companies. In all cases, HealthCor Partners seeks to be meaningfully involved with its portfolio companies by providing advice and assistance in the areas of strategy, management accountability, financial discipline, capital allocation, sales and marketing, regulatory affairs, acquisitions and divestitures, and accessing the public equity markets.